A Laboratory Planning and Design Firm…

Pathology & Clinical Laboratories

Science & Technology

Morph Design…Experts in Planning and Designing for Change

Test Menus, Procedures, Workflow, Research Priorities, Personnel, Equipment and Instrumentation all Morph.

Limited Time and Financial Resources Prohibit Disruptive, Serial Laboratory Facility Remodel Projects.

The Laboratory Facility must be able to Morph in Response to Multiple Generations of Emerging Technologies.

Morph Design…Creating the Evolving LaboratorySM

Morph's Unique Laboratory Industry Niche...

Laboratory Operations Expertise:

Biomedical Research Experience:

Firsthand experience in:

 

  • Clinical Laboratory Testing
  • Esoteric Testing
  • Laboratory Leadership from Frontline Supervision to the C-Suite
  •  LEAN Certification
Firsthand experience in:

  • Biomedical Research
  • Human Gene Mapping
  • Peer-Reviewed Publications
  • Broad spectrum use of Research Equipment & Instrumentation

Clinical Laboratory Planning & Design:

Science & Technology Laboratory Planning & Design:

Morph Design was founded in 2004. Morph has completed greater than 2 million square feet of Healthcare and Science & Technology Laboratories Nationally and Internationally.

 

Our projects include University Hospitals, Community Hospitals, Pediatric Hospitals, Cancer Hospitals, Reference Laboratories, Government Research Institutions, University Research Institutions.

From our Clients...

Morph is simply a first-rate partner. I was not able to fathom how truly functional, flexible and beautiful our space would be. Many other outside lab colleagues have commented on the exceptional nature of our space, and many have expressed outright envy.

Nathan Wood, MHA, CLS, MLS(ASCP)CM
Operations Manager, Pathology and Laboratory Medicine
UCSF Benioff Children’s Hospital Oakland

Contact

mailing address:

Morph Design, Inc.
223 N. Guadalupe Street, #113
Santa Fe, New Mexico 87501

310.850.6070 jshulkin@morphdesigninc.com
 

Copyright 2023, All Rights Reserved, Morph Design, Inc.